Detected ·
SRTD Biotech
€31.5MSeed
German biotech SRTD Biotech raised €31.5M in a seed round to develop next-gen mRNA drugs targeting cancer, autoimmune conditions, and fibrosis. Round led by Merieux Equity Partners with participation from Boehringer Ingelheim Venture Fund, HTGF, and Lilly Ventures.
- Website
- —
- linkedin.com/company/98363353
- Amount
- €31 500 000 EUR
- Stage
- Seed
- Event
- Funding round
- Detected
- 2026-11-10 12:07:06 UTC
- Signal ID
- 4a714c80-7257-4d43-a300-acb8e0e17fee
As the API returns it
{
"id": "4a714c80-7257-4d43-a300-acb8e0e17fee",
"created_at": "2026-11-10T12:07:06.077640Z",
"company_name": "SRTD Biotech",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/98363353",
"event_type": "funding",
"funding_amount": 31500000,
"funding_currency": "EUR",
"funding_stage": "seed",
"message": "*German biotech SRTD Biotech raised €31.5M in a seed round to develop next-gen mRNA drugs targeting cancer, autoimmune conditions, and fibrosis. Round led by Merieux Equity Partners with participation from Boehringer Ingelheim Venture Fund, HTGF, and Lilly Ventures.*"
}